Thinking about how to be a healthy older person is like thinking about glaciers crashing into Arctic seas as a result of climate change. Too far away to imagine, and we’ll worry when the effects reach our doorsteps. In reality, the challenge is here today asking all of us, at any age, to look ahead...
Read moreDelivered by Laetitia Bigger, Director, Vaccines Policy IFPMA welcomes WHO’s efforts in developing a framework to avert shortages. While supply is one factor, shortages are influenced by a range of issues, such as unpredictable country demand, complex regulatory requirements, and lack of timely communication as referenced in paper A70/20. We call for the timely dialogue...
Read moreDelivered by Paula Barbosa, Manager, Vaccines Policy IFPMA reiterate our support for the aim of the WHO PIP Framework to improve pandemic influenza preparedness and response. We welcome the progress made since the establishment of this Framework and remain committed partners in this initiative. While we continue to support the PIP Framework, we believe there...
Read moreDelivered by Nina Grundmann, Manager, Global Health Policy, IFPMA IFPMA commends the World Health Organization on the implementation of its AMR GAP and the 67 Member States which have now completed their national action plans. Our industry is at the forefront of leading action to address AMR and is committed to continuing to engage with...
Read moreAs falsified medicines are debated this week at the World Health Assembly, IFPMA shares what the biopharmaceutical is doing to combat this risk to individual and public health. If there’s one place not to take a gamble, it’s on whether or not a medicine is real or falsified. Yet in the last weeks alone...
Read moreThe International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) congratulates Dr Tedros Adhanom Ghebreyesus on his election as Director-General of the World Health Organization. His appointment is a reflection of Dr Tedros wide-ranging experience in health policy and practice and his qualities of leadership. Thomas Cueni, IFPMA Director General upon the election of Dr Tedros...
Read moreI must admit I had been somewhat skeptical about the “WHO Fair Pricing Forum” held last week in Amsterdam. There were multiple reasons for my apprehension. One concern was clearly that the notion of “fair” is pretty much in the eye of the beholder, another was that none of the 300 expected participants had...
Read moreNew Industry Alliance brings together research-based pharmaceutical companies, generics, biotech and diagnostic companies, to drive and measure industry progress to curb antimicrobial resistance. The AMR Industry Alliance will ensure that signatories collectively deliver on the commitments made in the Declaration (January 2016) and the Roadmap (September 2016) and will measure industry’s progress in the fight...
Read more